Ambitious AB Science Gets Masitinib Win For Severe Asthma
Drug In Trials For Seven Indications
Plagued by concerns on the integrity of data and compliance issues with its clinical practices, the French firm still believes masitinib could be effective for ALS, multiple sclerosis, cancers, asthma and even Alzheimer's.
